PETMED EXPRESS INC (PETS) — SEC Filings

Latest SEC filings for PETMED EXPRESS INC (PETS), explained in plain English.

Sentiment Overview: 4 bearish, 40 neutral, 1 mixed

Recent Filings (45)

• PetMed Express Files 8-K/A Amendment — 8-K/A · 2025-12-29T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. filed an amendment (8-K/A) on December 29, 2025, to its report originally filed on December 8, 2025. This amendment pertains to changes in
• PetMeds Plunges to $34M Loss on Goodwill Impairment, Sales Slide — 10-Q · 2025-12-19T00:00:00.000Z [bearish] Risk: high
  PETMED EXPRESS INC (PETS) reported a significant net loss of $34.152 million for the three months ended June 30, 2025, a stark contrast to the net income of $3.
• PetMed Express Sets Virtual Shareholder Meeting for Jan 2026 — DEF 14A · 2025-12-10T00:00:00.000Z [neutral] Risk: low
  PetMed Express, Inc. (PETS) is holding its 2025 Annual Meeting of Shareholders virtually on January 21, 2026, at 11:00 a.m. Eastern Time. Shareholders will vote
• 8-K Filing — 8-K · 2025-12-09T00:00:00.000Z [neutral]
• PetMed Express Files 8-K on Agreements and Officer Changes — 8-K · 2025-11-26T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. filed an 8-K on November 26, 2025, reporting on several key events. These include entering into a material definitive agreement, modificati
• PetMed Express Files 8-K on Financials and Listing Status — 8-K · 2025-11-13T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. filed an 8-K on November 13, 2025, reporting on its results of operations and financial condition. The filing also addresses a notice of de
• PetMed Express Files 8-K on Director Changes & Compensation — 8-K · 2025-10-21T00:00:00.000Z [neutral] Risk: medium
  On October 19, 2025, PetMed Express, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing al
• PetMeds Restates Financials, Eyes Omnichannel Growth & Telehealth — 10-K · 2025-10-14T00:00:00.000Z [mixed] Risk: high
  PetMed Express, Inc. (PETS) filed a comprehensive 10-K for the fiscal year ended March 31, 2025, which included restatements for fiscal years 2023 and 2024 due
• PetMed Express Faces Financial Reporting Issues — 8-K · 2025-10-07T00:00:00.000Z [neutral] Risk: high
  PetMed Express, Inc. filed an 8-K on October 7, 2025, reporting material impairments and a non-reliance on previously issued financial statements. The filing in
• PetMed Express Announces Board and Executive Changes — 8-K · 2025-09-12T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. announced on September 8, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure
• PetMed Express Faces Delisting Notice — 8-K · 2025-08-25T00:00:00.000Z [bearish] Risk: high
  PetMed Express, Inc. filed an 8-K on August 20, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, incorporated
• PetMed Express Announces Director Departure, Officer Compensation — 8-K · 2025-08-12T00:00:00.000Z [neutral] Risk: low
  PetMed Express, Inc. announced on August 11, 2025, the departure of Director Steven R. Zalesin. The company also reported on compensatory arrangements for certa
• PetMed Express Announces Board and Executive Compensation Changes — 8-K · 2025-07-28T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. announced on July 24, 2025, a change in its board of directors and executive compensation arrangements. Specifically, the company reported
• PetMed Express Faces Listing Rule Issues — 8-K · 2025-07-03T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. filed an 8-K on July 2, 2025, to report a notice of delisting or failure to satisfy a continued listing rule or standard, and also filed fi
• PetMed Express Files 8-K on July 1, 2025 — 8-K · 2025-07-01T00:00:00.000Z [neutral] Risk: low
  PetMed Express, Inc. filed an 8-K on July 1, 2025, reporting on events that occurred on the same date. The filing includes information related to Regulation FD
• PetMed Express Files 8-K on Financials — 8-K · 2025-06-16T00:00:00.000Z [neutral] Risk: low
  PetMed Express, Inc. filed an 8-K on June 16, 2025, to report on its Results of Operations and Financial Condition. The filing does not contain specific financi
• PetMed Express Files 8-K on Executive Changes — 8-K · 2025-04-09T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. filed an 8-K on April 9, 2025, reporting on the departure of directors, election of directors, appointment of officers, and compensatory ar
• PetMed Express Files Q3 2024 10-Q — 10-Q · 2025-02-10T00:00:00.000Z [neutral] Risk: low
  PetMed Express Inc. filed its 10-Q for the period ending December 31, 2024. The filing covers the third quarter of their fiscal year. Key financial data and ope
• PetMed Express Files 8-K/A Amendment — 8-K/A · 2024-12-18T00:00:00.000Z [neutral] Risk: low
  PetMed Express, Inc. filed an 8-K/A on December 18, 2024, to amend a previous filing related to events on December 3, 2024. The filing pertains to financial sta
• PetMed Express Files 8-K with Material Agreements & Bylaw Changes — 8-K · 2024-12-03T00:00:00.000Z [neutral] Risk: medium
  On December 3, 2024, PetMed Express, Inc. filed an 8-K report detailing several key events. These include entering into a material definitive agreement, modific
• SC 13G Filing — SC 13G · 2024-11-14T00:00:00.000Z [neutral]
• PetMed Express Files Q2 FY25 10-Q — 10-Q · 2024-11-07T00:00:00.000Z [neutral] Risk: medium
  PetMed Express Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the second qua
• PetMed Express Files 8-K on Financials — 8-K · 2024-11-06T00:00:00.000Z [neutral] Risk: low
  PetMed Express, Inc. filed an 8-K on November 6, 2024, reporting on its Results of Operations and Financial Condition, and filing Financial Statements and Exhib
• SC 13G Filing — SC 13G · 2024-10-10T00:00:00.000Z [neutral]
• PetMed Express Reports Board and Executive Compensation Changes — 8-K · 2024-09-27T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. filed an 8-K on September 27, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing indicat
• PetMed Express Elects New Directors, Updates Executive Pay — 8-K · 2024-09-12T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. announced on September 11, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new di
• PetMed Express Announces Director Changes and Compensation Updates — 8-K · 2024-08-08T00:00:00.000Z [neutral] Risk: medium
  On August 8, 2024, PetMed Express, Inc. filed an 8-K report detailing several key events. The company announced the election of new directors, including the app
• PetMed Express Files Q1 FY25 10-Q — 10-Q · 2024-08-07T00:00:00.000Z [neutral] Risk: medium
  PetMed Express Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the first quarter o
• PetMed Express Files 8-K on Financials — 8-K · 2024-08-06T00:00:00.000Z [neutral] Risk: low
  On August 6, 2024, PetMed Express, Inc. filed an 8-K report. The filing primarily concerns the company's financial condition and results of operations, with spe
• PetMed Express CFO Departs, Interim Appointed — 8-K · 2024-08-05T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. announced on August 2, 2024, the departure of its Chief Financial Officer, Jeffrey W. Atwood, effective August 5, 2024. The company also an
• SC 13G/A Filing — SC 13G/A · 2024-07-08T00:00:00.000Z [neutral]
• PetMed Express Files Proxy Statement Amendment — DEFA14A · 2024-07-02T00:00:00.000Z [neutral] Risk: low
  PetMed Express, Inc. (PETS) filed an amendment to its definitive proxy statement for the 2024 Annual Meeting. This filing, dated July 2, 2024, is an amendment t
• PetMed Express Elects New Directors — 8-K · 2024-06-24T00:00:00.000Z [neutral] Risk: low
  PetMed Express, Inc. announced on June 24, 2024, a change in its board of directors. Specifically, the company elected two new directors, Michael J. Bingle and
• PetMed Express Files 2024 10-K — 10-K · 2024-06-14T00:00:00.000Z [neutral] Risk: low
  PetMed Express Inc. filed its 10-K for the fiscal year ending March 31, 2024. The company, operating as a drug store retailer, is based in Delray Beach, Florida
• PetMed Express Files 8-K on Financials — 8-K · 2024-06-11T00:00:00.000Z [neutral] Risk: low
  PetMed Express, Inc. filed an 8-K on June 11, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and
• PetMed Express Reports Director Changes and Officer Compensation Updates — 8-K · 2024-05-31T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. filed an 8-K on May 31, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing indicates a d
• PetMed Express Names New CFO, CFO Departs — 8-K · 2024-05-20T00:00:00.000Z [neutral] Risk: medium
  PetMed Express, Inc. announced on May 20, 2024, the departure of its Chief Financial Officer, Jeffrey W. Atwood, effective May 24, 2024. The company also announ
• PetMed Express Files 8-K: Board & Compensation Updates — 8-K · 2024-04-29T00:00:00.000Z [neutral] Risk: low
  PetMed Express, Inc. filed an 8-K on April 29, 2024, reporting changes in its board of directors and executive compensation arrangements. The filing also includ
• PetMed Express Restates 2023 Financials — 10-K/A · 2024-04-15T00:00:00.000Z [neutral] Risk: medium
  PetMed Express Inc. filed a 10-K/A amendment on April 15, 2024, to restate its financial results for the fiscal year ending March 31, 2023. The filing indicates
• PetMed Express Reports Listing Standard Failure, Transfer of Listing — 8-K · 2024-02-15T00:00:00.000Z [bearish] Risk: high
  PetMed Express, Inc. filed an 8-K on February 15, 2024, reporting an event that occurred on February 13, 2024. The filing indicates a "Notice of Delisting or Fa
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• SC 13G Filing — SC 13G · 2024-02-13T00:00:00.000Z [neutral]
• PetMed Express to Restate Financials Due to PetCareRx Acquisition Errors — 8-K · 2024-02-08T00:00:00.000Z [bearish] Risk: low
  PetMed Express, Inc. (PETS) filed an 8-K on February 8, 2024, reporting that it will restate its previously issued financial statements. This restatement is due
• BlackRock Amends PetMed Express Stake (SC 13G/A) — SC 13G/A · 2024-01-25T00:00:00.000Z [neutral]
  BlackRock, Inc. filed an amended SC 13G/A on January 25, 2024, indicating a change in its ownership stake in PetMed Express Inc. as of December 31, 2023. This f
• PETS Files Routine 8-K for 'Other Event' on Jan 5, 2024 — 8-K · 2024-01-08T00:00:00.000Z [neutral]
  PetMed Express, Inc. (PETS) filed an 8-K on January 8, 2024, reporting an 'Other Event' that occurred on January 5, 2024. This filing is a routine disclosure, i